Report post

What is the target price for Denali Therapeutics (dnli) stock?

8 analysts have issued 1 year target prices for Denali Therapeutics' shares. Their DNLI share price targets range from $28.00 to $95.00. On average, they anticipate the company's stock price to reach $41.22 in the next twelve months. This suggests a possible upside of 145.1% from the stock's current price.

Is Denali Therapeutics a good stock to buy?

The company's average rating score is 3.00, and is based on 8 buy ratings, no hold ratings, and no sell ratings. Denali Therapeutics has only been the subject of 4 research reports in the past 90 days. Forget Nvidia, Microsoft or Google. Our tech expert and venture capitalist Luke Lango believes this is Elon Musk’s favorite A.I. stock. Why?

When did Denali Therapeutics IPO?

Denali Therapeutics (DNLI) raised $149 million in an initial public offering (IPO) on Friday, December 8th 2017. The company issued 8,300,000 shares at a price of $17.00-$19.00 per share.

The World's Leading Crypto Trading Platform

Get my welcome gifts